إعلان مُمول
DMCA
What is Leqembi? The first Alzheimer’s treatment approved today in Saudi Arabia
Saudi Arabia’s SFDA has approved Leqembi (lecanemab), the Kingdom’s first Alzheimer’s treatment. This innovative drug slows disease progression by targeting beta-amyloid plaques, protein clumps that disrupt brain cell communication. Approved for patients with mild symptoms and specific genetic profiles, Leqembi requires careful monitoring to manage side effects, marking a major step forward in Alzheimer’s care through advanced biotechnology.
English
नेपाली
हिन्दी
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
French
অসমীয়া
বাংলা